New Study by Emmanuel J Favaloro and Team Questions Consistency in APS Classification and Diagnosis
Emmanuel J Favaloro, Lead Scientist at Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, posted on LinkedIn:
”Latest publication from the Sydney Centres for Thrombosis and Haemostasis at Westmead Hospital.
Highlights the variability in solid-phase antiphospholipid antibody (aPL) test results on different testing platforms.
Also highlights the decreasing use of ELISA-based procedures, and the disconnection between classification criteria for antiphospholipid syndrome (APS), as used for research, versus diagnostic criteria (see also here).
The latest publication is available for free download for the next 50 days using this link.”
Title: A contemporary analysis of solid-phase antiphospholipid antibody testing: implications for classification or diagnosis of antiphospholipid syndrome
Authors: Caitlin Thirunavukarasu, Leonardo Pasalic, Emmanuel J. Favaloro
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy